Home About us About us
x
Search
Innovating Healthcare Solutions About
Huayi Pharmaceutical

Huayi Pharmaceuticals (Anhui) Co., Ltd. is the first pharmaceutical company passing European certification in Anhui and dedicated to providing CDMO services for oral preparations. The company focuses on manufacturing and R&D and expand services into areas such as API development and clinical services etc. Moreover, Huayi actively innovate its service model to provide services such as Joint venture cooperation, MA application in both China and Europe etc. to assist customers to secure a competitive edge in the pharmaceutical markets.

Since its establishment, Huayi has been committed to providing comprehensive, high-quality CDMO services for oral preparations to pharmaceutical companies worldwide and has successfully passed 5 EU certifications and over 40 domestic and international official inspections. With its quality advantages and standardized operations under system with dual certification in China & Europe, Huayi has earned wide recognition and acclaim within the industry. Through years of dedication, Huayi has gradually built an open CDMO platform for international markets with oral preparation manufacturing at its core, contributing significantly to the development of the global pharmaceutical industry.

Adhering to the corporate value of “For a better world”, Huayi consistently prioritizes social benefits and is committed to improving public health. Upholding the corporate spirit of “For people’s health”, Huayi provides customers with services of high efficient, high quality and controllable cost through pragmatic execution, evidence-based approaches, and bold innovation and remain steadfast in our mission to make high quality drugs at affordable cost. Looking ahead, Huayi sincerely looks forward to cooperating with our customers to expand both domestic and international pharmaceutical markets and to contribute to a healthier future for humanity.

3Billion

tablets/capsules manufactured per year on a contract basis

300+

products successfully developed and commercialized

40+

Domestic and international official quality inspections

Milestone

2024

Passed the fifth EU inspection in November 2024

Synthesis laboratory constructed

Phase I Preparation Building in the New Site (Shenyang Road Site) Put Into Use

High potent solid preparation workshop under construction

The Fourth Council Member Unit of the All-China Federation of Industry and Commerce Association of Pharmaceutical Commerce

Top 20 Chinese Pharmaceutical CDMO Enterprises in 2023

Main Structure Construction for Phase I Preparation Building in the New Site (Shenyang Road Site) completed

Construction of synthesis laboratory started

Construction of highly potent solid preparation workshop started

Exports to EU reached 2.5 billion tablets

First domestic product commercialized

2023

2022

On September 13, 2022, the company was elected as the Chairman Unit of Anhui Preparation CDMO Industry Alliance

Top 20 Chinese Pharmaceutical CDMO Enterprises in 2022

2022 (Industry) Leading Enterprise

On October 8, 2021, Huayi’s Technical Center was established.

In June 2021, the company passed the remote re-inspection by MHRA.

2021

2020

Passed the fifth EU inspection in November 2024

Synthesis laboratory constructed

Phase I Preparation Building in the New Site (Shenyang Road Site) Put Into Use

High potent solid preparation workshop under construction

On July 14, 2020, Huayi produced the first bottle of oral liquids preparation with the Oral Liquid Preparation Workshop put into operation.

2019

2018

In 2018, contract manufacturing output reached 1.6 billion units and we began construction of our oral liquid preparation workshop and high-potency workshop.

In 2016, the company passed re-inspection by MHRA without any major deficiencies. The workshop extension passed MHRA certification and the company’s annual capacity was increased to 3 billion units.

2016

2012

In 2012, the company passed re-inspection by MHRA.

In 2010, we passed the on-site inspection by MHRA and received EU GMP certification. We became the 12th solid dose pharmaceutical plant to pass EU GMP accreditation in China. We started manufacture for the EU market.

2010

2006

In 2006, Huayi Pharmaceutical (Anhui) Co., Ltd., a Sino-British joint venture, was established. Land was purchased and the factory designed.

Honors
Read more
Play Video
加载中...